These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
436 related articles for article (PubMed ID: 25090938)
1. Construction of a Streptococcus iniae sortase A mutant and evaluation of its potential as an attenuated modified live vaccine in Nile tilapia (Oreochromis niloticus). Wang J; Zou LL; Li AX Fish Shellfish Immunol; 2014 Oct; 40(2):392-8. PubMed ID: 25090938 [TBL] [Abstract][Full Text] [Related]
2. Development and efficacy of a novobiocin-resistant Streptococcus iniae as a novel vaccine in Nile tilapia (Oreochromis niloticus). Pridgeon JW; Klesius PH Vaccine; 2011 Aug; 29(35):5986-93. PubMed ID: 21708205 [TBL] [Abstract][Full Text] [Related]
3. Construction of a Streptococcus agalactiae phoB mutant and evaluation of its potential as an attenuated modified live vaccine in golden pompano, Trachinotus ovatus. Cai X; Wang B; Peng Y; Li Y; Lu Y; Huang Y; Jian J; Wu Z Fish Shellfish Immunol; 2017 Apr; 63():405-416. PubMed ID: 27884809 [TBL] [Abstract][Full Text] [Related]
4. Genome-wide analysis revealed the virulence attenuation mechanism of the fish-derived oral attenuated Streptococcus iniae vaccine strain YM011. Liu Y; Li L; Yu F; Luo Y; Liang W; Yang Q; Wang R; Li M; Tang J; Gu Q; Luo Z; Chen M Fish Shellfish Immunol; 2020 Nov; 106():546-554. PubMed ID: 32781206 [TBL] [Abstract][Full Text] [Related]
5. Staphylococcus epidermidis ΔSortase A strain elicits protective immunity against Staphylococcus aureus infection. Tan C; Wang J; Hu Y; Wang P; Zou L Antonie Van Leeuwenhoek; 2017 Jan; 110(1):133-143. PubMed ID: 27757703 [TBL] [Abstract][Full Text] [Related]
6. Immunoproteomic analysis of the antibody response obtained in Nile tilapia following vaccination with a Streptococcus iniae vaccine. LaFrentz BR; Shoemaker CA; Klesius PH Vet Microbiol; 2011 Sep; 152(3-4):346-52. PubMed ID: 21601381 [TBL] [Abstract][Full Text] [Related]
7. Development and efficacy of Streptococcus iniae live-attenuated vaccines in Nile tilapia, Oreochromis niloticus. Heckman TI; Shahin K; Henderson EE; Griffin MJ; Soto E Fish Shellfish Immunol; 2022 Feb; 121():152-162. PubMed ID: 34965443 [TBL] [Abstract][Full Text] [Related]
8. Development of live attenuated Streptococcus agalactiae vaccine for tilapia via continuous passage in vitro. Li LP; Wang R; Liang WW; Huang T; Huang Y; Luo FG; Lei AY; Chen M; Gan X Fish Shellfish Immunol; 2015 Aug; 45(2):955-63. PubMed ID: 26087276 [TBL] [Abstract][Full Text] [Related]
9. Identification and expression profile of multiple genes in Nile tilapia in response to formalin killed Streptococcus iniae vaccination. Pridgeon JW; Klesius PH Vet Immunol Immunopathol; 2011 Aug; 142(3-4):201-6. PubMed ID: 21640389 [TBL] [Abstract][Full Text] [Related]
10. Streptococcus iniae phosphoglucomutase is a virulence factor and a target for vaccine development. Buchanan JT; Stannard JA; Lauth X; Ostland VE; Powell HC; Westerman ME; Nizet V Infect Immun; 2005 Oct; 73(10):6935-44. PubMed ID: 16177373 [TBL] [Abstract][Full Text] [Related]
11. Streptococcus iniae beta-hemolysin streptolysin S is a virulence factor in fish infection. Locke JB; Colvin KM; Varki N; Vicknair MR; Nizet V; Buchanan JT Dis Aquat Organ; 2007 Jun; 76(1):17-26. PubMed ID: 17718161 [TBL] [Abstract][Full Text] [Related]
12. An effective live attenuated vaccine against Streptococcus agalactiae infection in farmed Nile tilapia (Oreochromis niloticus). Zhang D; Gao Y; Li Q; Ke X; Liu Z; Lu M; Shi C Fish Shellfish Immunol; 2020 Mar; 98():853-859. PubMed ID: 31751658 [TBL] [Abstract][Full Text] [Related]
13. Construction of Streptococcus agalactiae sialic acid mutant and evaluation of its potential as a live attenuated vaccine in Nile tilapia (Oreochromis niloticus). Hao J; Wang S; Wei Z; Zhang Q; Wu Z; Lin Y; Yang J; Zhang J; Zhang D; Li A J Appl Microbiol; 2022 Oct; 133(4):2403-2416. PubMed ID: 35801502 [TBL] [Abstract][Full Text] [Related]
14. Development of attenuated erythromycin-resistant Streptococcus agalactiae vaccine for tilapia (Oreochromis niloticus) culture. Liu L; Lu DQ; Xu J; Luo HL; Li AX J Fish Dis; 2019 May; 42(5):693-701. PubMed ID: 30893488 [TBL] [Abstract][Full Text] [Related]
15. Development of live attenuated Streptococcus agalactiae as potential vaccines by selecting for resistance to sparfloxacin. Pridgeon JW; Klesius PH Vaccine; 2013 May; 31(24):2705-12. PubMed ID: 23583891 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the link between gyrodactylosis and streptococcosis of Nile tilapia, Oreochromis niloticus (L.). Xu DH; Shoemaker CA; Klesius PH J Fish Dis; 2007 Apr; 30(4):233-8. PubMed ID: 17394525 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of Streptococcus agalactiae (group B) vaccine in tilapia (Oreochromis niloticus) by intraperitoneal and bath immersion administration. Evans JJ; Klesius PH; Shoemaker CA Vaccine; 2004 Sep; 22(27-28):3769-73. PubMed ID: 15315858 [TBL] [Abstract][Full Text] [Related]
19. The involvement of sortase A in high virulence of STSS-causing Streptococcus suis serotype 2. Wang C; Li M; Feng Y; Zheng F; Dong Y; Pan X; Cheng G; Dong R; Hu D; Feng X; Ge J; Liu D; Wang J; Cao M; Hu F; Tang J Arch Microbiol; 2009 Jan; 191(1):23-33. PubMed ID: 18716756 [TBL] [Abstract][Full Text] [Related]
20. The conserved surface M-protein SiMA of Streptococcus iniae is not effective as a cross-protective vaccine against differing capsular serotypes in farmed fish. Aviles F; Zhang MM; Chan J; Delamare-Deboutteville J; Green TJ; Dang C; Barnes AC Vet Microbiol; 2013 Feb; 162(1):151-9. PubMed ID: 22989514 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]